Literature DB >> 35080509

2021 ELSO Adult and Pediatric Anticoagulation Guidelines.

Ali B V McMichael1, Lindsay M Ryerson2, Damian Ratano3,4, Eddy Fan3, David Faraoni5, Gail M Annich6.   

Abstract

DISCLAIMER: These guidelines for adult and pediatric anticoagulation for extracorporeal membrane oxygenation are intended for educational use to build the knowledge of physicians and other health professionals in assessing the conditions and managing the treatment of patients undergoing ECLS / ECMO and describe what are believed to be useful and safe practice for extracorporeal life support (ECLS, ECMO) but these are not necessarily consensus recommendations. The aim of clinical guidelines are to help clinicians to make informed decisions about their patients. However, adherence to a guideline does not guarantee a successful outcome. Ultimately, healthcare professionals must make their own treatment decisions about care on a case-by-case basis, after consultation with their patients, using their clinical judgment, knowledge and expertise. These guidelines do not take the place of physicians' and other health professionals' judgment in diagnosing and treatment of particular patients. These guidelines are not intended to and should not be interpreted as setting a standard of care or be deemed inclusive of all proper methods of care nor exclusive of other methods of care reasonably directed to obtaining the same results. The ultimate judgment must be made by the physician and other health professionals and the patient in light of all the circumstances presented by the individual patient, and the known variability and biological behavior of the clinical condition. These guidelines reflect the data at the time the guidelines were prepared; the results of subsequent studies or other information may cause revisions to the recommendations in these guidelines to be prudent to reflect new data, but ELSO is under no obligation to provide updates. In no event will ELSO be liable for any decision made or action taken in reliance upon the information provided through these guidelines.
Copyright © ELSO 2022.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35080509     DOI: 10.1097/MAT.0000000000001652

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

Review 1.  Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions.

Authors:  Alain Combes; Daniel Brodie; Nadia Aissaoui; Thomas Bein; Gilles Capellier; Heidi J Dalton; Jean-Luc Diehl; Stefan Kluge; Daniel F McAuley; Matthieu Schmidt; Arthur S Slutsky; Samir Jaber
Journal:  Intensive Care Med       Date:  2022-08-09       Impact factor: 41.787

Review 2.  Bleeding During Veno-Venous ECMO: Prevention and Treatment.

Authors:  Johannes Kalbhenn; Barbara Zieger
Journal:  Front Med (Lausanne)       Date:  2022-05-23

Review 3.  Respiratory indications for ECMO: focus on COVID-19.

Authors:  Alain Combes; Arthur S Slutsky; Daniel Brodie; Alexander Supady; Ryan P Barbaro; Luigi Camporota; Rodrigo Diaz; Eddy Fan; Marco Giani; Carol Hodgson; Catherine L Hough; Christian Karagiannidis; Matthias Kochanek; Ahmed A Rabie; Jordi Riera
Journal:  Intensive Care Med       Date:  2022-08-09       Impact factor: 41.787

4.  An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation.

Authors:  Yuan Teng; Shujie Yan; Gang Liu; Song Lou; Yang Zhang; Bingyang Ji
Journal:  Front Med (Lausanne)       Date:  2022-06-29

Review 5.  Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children.

Authors:  Madhuradhar Chegondi; Niranjan Vijayakumar; Balagangadhar R Totapally
Journal:  Pediatr Rep       Date:  2022-07-11

Review 6.  Anticoagulation Strategies during Extracorporeal Membrane Oxygenation: A Narrative Review.

Authors:  Sasa Rajsic; Robert Breitkopf; Dragana Jadzic; Marina Popovic Krneta; Helmuth Tauber; Benedikt Treml
Journal:  J Clin Med       Date:  2022-08-31       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.